Medium chain triglyceride diet reduces anxiety-like behaviors and enhances social competitiveness in rats. (August 2018)
- Record Type:
- Journal Article
- Title:
- Medium chain triglyceride diet reduces anxiety-like behaviors and enhances social competitiveness in rats. (August 2018)
- Main Title:
- Medium chain triglyceride diet reduces anxiety-like behaviors and enhances social competitiveness in rats
- Authors:
- Hollis, Fiona
Mitchell, Ellen Siobhan
Canto, Carles
Wang, Dongmei
Sandi, Carmen - Abstract:
- Abstract: Medium-chain triglycerides (MCT) are emerging as unique dietary supplements that are potentially relevant for the amelioration of brain dysfunctions. MCT are converted into ketones and free medium chain fatty acids that, in the brain, are highly effective energy sources to mitochondria and potentially less harmful than glucose metabolism to neurons. Given the recently established link between mitochondrial dysfunction and high anxiety and depression, we performed this study to investigate the effectiveness of an MCT-enriched diet to ameliorate anxiety- and depression-related behaviors in rats. Male rats were distributed into groups, according to their anxiety-like behaviors in the elevated plus maze. Each group was given either MCT-supplemented diet or an isocaloric control diet for fifteen days. Starting from the eighth day of diet, rats were exposed to different behavioral tests. MCT-fed rats exhibited reduced anxiety-like behaviors and enhanced social competitiveness, while their coping responses in the forced swim test were not affected by the treatment. When evaluated at the end of the two-week MCT diet, mitochondrial respiration was reduced in the medial prefrontal cortex (mPFC) while unchanged in the nucleus accumbens. In the mPFC, enzymes related to glycolysis and oxidative phosphorylation were also decreased by MCT diet, while proteins controlling glucose and glutamate transport were increased. Altogether, our findings strongly suggest the effectiveness ofAbstract: Medium-chain triglycerides (MCT) are emerging as unique dietary supplements that are potentially relevant for the amelioration of brain dysfunctions. MCT are converted into ketones and free medium chain fatty acids that, in the brain, are highly effective energy sources to mitochondria and potentially less harmful than glucose metabolism to neurons. Given the recently established link between mitochondrial dysfunction and high anxiety and depression, we performed this study to investigate the effectiveness of an MCT-enriched diet to ameliorate anxiety- and depression-related behaviors in rats. Male rats were distributed into groups, according to their anxiety-like behaviors in the elevated plus maze. Each group was given either MCT-supplemented diet or an isocaloric control diet for fifteen days. Starting from the eighth day of diet, rats were exposed to different behavioral tests. MCT-fed rats exhibited reduced anxiety-like behaviors and enhanced social competitiveness, while their coping responses in the forced swim test were not affected by the treatment. When evaluated at the end of the two-week MCT diet, mitochondrial respiration was reduced in the medial prefrontal cortex (mPFC) while unchanged in the nucleus accumbens. In the mPFC, enzymes related to glycolysis and oxidative phosphorylation were also decreased by MCT diet, while proteins controlling glucose and glutamate transport were increased. Altogether, our findings strongly suggest the effectiveness of MCT diet to exert anxiolytic effects. In the brain, our results point to the mPFC as a brain region in which MCT supplementation improves transport and control of energy substrates. Highlights: A medium-chain triglycerides (MCT) diet decreases anxiety-like behavior. An MCT diet enhances social dominance and sociability in high anxious rats. MCT diet decreases upregulated mPFC mitochondrial function in high anxious rats. MCT supplementation modulates glutamate reuptake in the mPFC. … (more)
- Is Part Of:
- Neuropharmacology. Volume 138(2018)
- Journal:
- Neuropharmacology
- Issue:
- Volume 138(2018)
- Issue Display:
- Volume 138, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 138
- Issue:
- 2018
- Issue Sort Value:
- 2018-0138-2018-0000
- Page Start:
- 245
- Page End:
- 256
- Publication Date:
- 2018-08
- Subjects:
- Mitochondria -- Oxidative phosphorylation -- Glucose transporter -- Glycolysis -- Hexokinase -- Social dominance -- Anxiety
Neuropsychopharmacology -- Periodicals
Autonomic Agents -- Periodicals
Neuropsychopharmacologie -- Périodiques
Neuropsychopharmacology
Periodicals
Electronic journals
615.78 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00283908 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuropharm.2018.06.017 ↗
- Languages:
- English
- ISSNs:
- 0028-3908
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.517500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12834.xml